Cumulatively, these studies establish that circulating CD45RO+ Tregs from CRC patients and healthy subjects may express markers found in tumor-infiltrating Tregs, including TIGIT, OX40, and CD30. The gene discussed is TIGIT; the disease is neoplasm.